ArticleThoracic cancer2023

Real-world treatment and prognostic factors for survival in ALK+ non-small cell lung cancer (NSCLC) patients with brain metastases in China.

Na Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.